Vaccine Production, Ordering, and Distribution
Seasonal Influenza Vaccines for 2009-2010
| Manufacturer |
Trade Name |
Presentation |
Mercury
Content
(mcg
Hg/0.5
mL dose) |
Age Indication |
|
CSL Biotherapies |
Afluria |
0.5 mL (single-dose
syringe) |
0 |
36 months & older |
| 24.5 |
6 months & older |
| 5.0 mL (mullti-dose vial) |
|
GlaxoSmithKline (GSK) |
Fluarix |
0.5 mL
(single-dose syringe) |
0 |
3 years & older |
ID
Biomedical Corporation of Quebec
(Distributed by GlaxoSmithKline) |
FluLaval |
5.0 mL (10-dose vial) |
25 |
18 years & older |
|
MedImmune |
FluMist |
0.2 mL
(single-use sprayer) |
0 |
2 through 49 years |
|
Novartis Vaccines |
Fluvirin |
0.5 mL (single-dose syringe) |
<1 |
4 years and older |
| 5.0 mL (10-dose vial) |
25 |
| Agiflu |
0.5 mL (single-dose syringe) |
0 |
18 years & older |
|
sanofi pasteur |
FluZone |
0.25 mL
(single-dose syringe) |
0 |
6 through 35
months |
| 0.5 mL
(single-dose syringe) |
0 |
36 months & older |
| 0.5 mL
(single-dose vial) |
0 |
36 months & older |
| 5.0 mL
(multi-dose vial) |
25 |
6 months & older |
Influenza A (H1N1) 2009 Monovalent Vaccines
| Manufacturer |
Presentation |
Mercury Content
(mcg Hg/0.5 mL dose) |
Age Indication |
|
CSL Biotherapies |
0.5 mL (single-dose syringe) |
0 |
36 months & older |
| 24.5 |
6 months & older |
| 5.0 mL (multi-dose vial) |
ID
Biomedical Corporation of Quebec
(Distributed by GlaxoSmithKline) |
5.0 mL (10-dose
vial) |
25 |
18 years & older |
|
MedImmune |
0.2 mL (single-use sprayer) |
0 |
2 through 49 years |
|
Novartis Vaccines |
0.5 mL
(single-dose syringe) |
<1 |
4 years and older |
| 5.0 mL (10-dose
vial) |
25 |
|
sanofi pasteur |
0.25 mL (single-dose syringe) |
0 |
6 through 35 months |
| 0.5 mL (single-dose syringe) |
0 |
36 months & older |
| 0.5 mL (single-dose vial) |
0 |
36 months & older |
| 5.0 mL (multi-dose vial) |
25 |
6 months & older |
Seasonal Influenza Vaccine Ordering
Most providers order influenza vaccine for the coming vaccination season in the
winter and spring
of the preceding year. Depending on many factors, orders can be placed direct
with the
manufacturer, with a distributor, the state's VFC program, or a group purchasing
arrangement.
Once the vaccination season is under way, the
Influenza Vaccine Availability Tracking System (IVATS) also becomes
operational. IVATS enables healthcare providers to view at a glance which
distributors have vaccine available to sell.
|
Order from a manufacturer:
To order either
Fluarix (GSK) or
FluZone (sanofi
pasteur), contact the manufacturer.
Order from a distributor:
To order FluLaval (GSK), FluMist (MedImmune), or FluVirin (Novartis), contact
one of the many
distributors that you will find
here.
View vaccine currently for sale on the
Influenza Vaccine
Availability Tracking System (IVATS), a product of the
National
Influenza Vaccine Summit. |
H1N1 Influenza Vaccine Ordering and Distribution
View a flow chart of the ordering process and distribution chain for both
seasonal and H1N1 influenza vaccines.
Read a report about how the distribution process for H1N1 and seasonal
influenza vaccine differs and how medical products, including vaccine, are
allocated in times of high demand or scarcity. Also included in the report are
links to each state health department's website that explain how healthcare
providers should register to be a provider of H1N1 vaccine, and more.
Interested in Learning More About Influenza
Vaccine Production?
Read a report
from the Health Industry Distributors Association, a non-profit trade
association of medical products distributors who service healthcare providers,
that explains the process that determines when and how vaccine reaches doctors,
hospitals, nursing homes, and others.
Understanding the Dynamics of Influenza Vaccine Supply and Demand -- Five
Issue Briefs. This series of briefs were prepared for the Assistant Secretary
for Planning and Evaluation of the Department of Health and Human Services in
October 2005.
Overview -- Summary and Assessment: roles and responsibilities of the
influenza vaccine stakeholders.
Vaccine Economics: characteristics of the influenza vaccine market, industry
regulatory requirements for vaccine productions, and factors affecting the
profitability of vaccine production.
Who Buys It and Who Sells It: the vaccine supply chain and potential means
for facilitating vaccine purchase and distribution.
Vaccine Manufacturing: the unique characteristics of the influenza vaccine,
the structure of the industry, decisions about the amount of vaccine produced
each year, investments in new technologies, and other factors.
The Chicken and the Egg: factors that impact the demand for vaccine and how
they can affect supply. |
|
HCP Home
